Luminetx Corp. (Luminetx) and AccuVein LLC (AccuVein) have entered into a settlement agreement that resolves the legal disputes between them relating to Luminetx’s patent. AccuVein has agreed to license the Luminetx patents. Both parties stated that the resolution was in the best interest of their companies and their customers allowing them to offer their products to this growing worldwide marketplace. The remaining terms of the agreement are confidential.

Luminetx discovers, develops and commercializes medical product and biometric technologies.

AccuVein applies technologies to important healthcare challenges.